載入...

A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.

A phase I study to determine the maximum tolerated dose and toxicity of gemcitabine when given as a 24 h infusion to patients with inoperable non-small-cell lung cancer (NSCLC). A total of 24 patients with unresectable stage IIIa-IV NSCLC were entered into the study. Gemcitabine was administered as...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Anderson, H., Thatcher, N., Walling, J., Hansen, H.
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 1996
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2074628/
https://ncbi.nlm.nih.gov/pubmed/8695365
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!